Search Results for:
-
Agios Files for $86M IPO to Support Cancer Trials
Agios Pharmaceuticals Inc., of Cambridge, Mass., filed for an initial public offering (IPO) to raise up to $86 million to fund development of its pipeline in cancer and inborn errors of metabolism (IEMs), a subset of orphan genetic metabolic diseases -
Dermira Takes in $35M in Funding to Enhance Pipeline
last year. (See BioWorld Today, July 20, 2011, and Sept. 5, 2012.) Antibiotic developer Paratek Pharmaceuticals Inc., a potential competitor with tetracycline-derived compound PTK-AR01 under investigation in acne and rosacea, also filed and priced but has not yet closed an initial public offering. (See BioWorld Today, Oct. 1, 2012, and March 21, 2013.) And new entrants pursuing acne continue to come -
Competition Shaping up in U.S. Biosimilars Game
But biosimilars offer no improvement, so the only incentive for trial participation might be getting the drug for a little less, Craig Wheeler, president and CEO of Momenta Pharmaceuticals Inc., told BioWorld Today -
Clinic Roundup
Ariad Pharmaceuticals Inc., of Cambridge, Mass., said it started a Phase II trial of Iclusig (ponatinib) in adults with metastatic and/or unresectable gastrointestinal stromal tumors (GIST -
Appointments and Advancements
Achillion Pharmaceuticals Inc., of New Haven, Conn., named Milind Deshpande president and CEO...Altherx Pharmaceuticals Inc., of Exton, Pa., added Michael R. Dougherty to its board...Innovus Pharmaceuticals Inc., of La Jolla, Calif., named Morgan Brown executive vice president and chief financial officer -
Amira Pharmaceuticals Inc.
-
Amphastar Pharmaceuticals Inc.
-
Ampio Pharmaceuticals Inc.
-
Amplyx Pharmaceuticals Inc.
-
Anacor Pharmaceuticals Inc.
-
Angiotech Pharmaceuticals Inc.
-
Angstrom Pharmaceuticals Inc.
-
Anthera Pharmaceuticals Inc.
-
APP Pharmaceuticals Inc.
-
Aquinox Pharmaceuticals Inc.
-
Aragon Pharmaceuticals Inc.
-
Arena Pharmaceuticals Inc.
-
Ariad Pharmaceuticals Inc.
-
aRigen Pharmaceuticals Inc.
-
Arisaph Pharmaceuticals Inc.
Category
Current Filters
- xPharmaceuticals Inc
Related Keywords
Categories
- x BioWorld Today (14127)
- x BioWorld Insight (3060)
- x BioWorld International (717)
- x Bio Perspectives (325)
- x State of the Industry Report (316)
- x Bioscan (211)
- x BioWorld Genomics Review (148)
- x BioWorld Phase III Report (139)
- x Executive Compensation Report (105)
- x BioWorld Snapshots (86)
- x Top 25 Drug Report (52)
- x Biotech Innovations (32)
- x Market-Leading Biotech Drugs (8)
- x RNAi Report (5)